title: Response to Fibrosis progression in patients treated for hepatitis C recurrence.
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Renumathy
authors.initials: R
authors.lastname: Dhanasekaran
authors.affiliation: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: William
authors.initials: W
authors.lastname: Sanchez
authors.affiliation: Intermountain Transplant Center, Intermountain Medical Center, Murray, UT, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Charlton
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000473:pathology*; D008103:Liver Cirrhosis / Q000821:virology*; D016031:Liver Transplantation; D008297:Male
chemical_list: D000998:Antiviral Agents